07-03-2024 |
PM |
|
EYPT |
EyePoint Pharmaceuticals, Inc. |
902.86 |
-0.33 |
-0.60 |
-0.61 |
EyePoint Pharmaceuticals GAAP EPS of -$0.33 beats by $0.16, revenue of $14M beats by $5.3M [3/7/2024 7:04 AM] |
25.24 |
-0.50 (-1.94%) |
26.26 |
0.52 (2.02%) |
2.21 - 30.99 |
681,481 |
1,200,000 |
4,242 |
|
|
01-11-2023 |
PM |
|
EYPT |
EyePoint Pharmaceuticals, Inc. |
199.76 |
-0.33 |
-0.62 |
-0.49 |
EyePoint Pharmaceuticals beats Q3 top and bottom line estimates [11/1/2023 7:20 AM] |
7.21 |
1.20 (19.85%) |
0.0 |
0.0 (0.00%) |
2.19 - 15.63 |
854,698 |
510,000 |
0 |
|
|
02-08-2023 |
PM |
|
EYPT |
EyePoint Pharmaceuticals, Inc. |
428.77 |
-0.61 |
0.41 |
-0.52 |
EyePoint Pharmaceuticals misses top and bottom line estimates [8/2/2023 7:11 AM] |
12.80 |
0.10 (0.79%) |
11.85 |
-0.85 (-6.69%) |
2.19 - 12.98 |
741,576 |
600,000 |
63,224 |
|
|
03-05-2023 |
PM |
7:00 AM ET (May 3) |
EYPT |
EyePoint Pharmaceuticals, Inc. |
227.76 |
-0.56 |
-0.65 |
-0.52 |
EyePoint Pharmaceuticals GAAP EPS of -$0.56 beats by $0.13, revenue of $7.68M beats by $0.11M [5/3/2023 7:10 AM] |
7.96 |
1.46 (22.57%) |
6.99 |
0.50 (7.70%) |
2.19 - 12.32 |
1,060,661 |
3,590,000 |
5,650 |
|
|
02-03-2023 |
PM |
7:00 AM ET (Mar 2) |
EYPT |
EyePoint Pharmaceuticals, Inc. |
126.45 |
-0.61 |
-0.62 |
-0.59 |
EyePoint Pharmaceuticals GAAP EPS of -$1.16 misses by $0.54, revenue of $10.53M beats by $0.13M [3/2/2023 7:03 AM] |
2.87 |
-0.30 (-9.46%) |
0.0 |
0.0 (0.00%) |
2.19 - 14.41 |
327,804 |
200,000 |
0 |
|
|
02-11-2022 |
PM |
7:00 AM ET (Nov 2) |
EYPT |
EyePoint Pharmaceuticals, Inc. |
183.99 |
-0.49 |
-0.70 |
-0.58 |
EyePoint Pharmaceuticals GAAP EPS of -$0.49 beats by $0.16, revenue of $10.01M misses by $0.91M [11/2/2022 7:12 AM] |
5.15 |
-0.27 (-4.98%) |
5.42 |
0.0 (0.00%) |
4.89 - 21.50 |
145,306 |
90,000 |
684 |
|
|
03-08-2022 |
PM |
7:30 AM ET (Aug 3) |
EYPT |
EyePoint Pharmaceuticals, Inc. |
364.30 |
-0.52 |
-0.57 |
-0.35 |
EyePoint Pharmaceuticals GAAP EPS of -$0.52 misses by $0.01, revenue of $11.6M beats by $0.74M [8/3/2022 7:01 AM] |
10.15 |
0.87 (9.38%) |
9.28 |
0.0 (0.00%) |
7.00 - 21.50 |
156,940 |
210,000 |
82,277 |
|
|
04-05-2022 |
PM |
7:00 AM ET (May 4) |
EYPT |
EyePoint Pharmaceuticals |
385.00 |
-0.52 |
-0.50 |
0.00 |
EyePoint Pharmaceuticals GAAP EPS of -$0.56 in-line, revenue of $9.3M misses by $0.59M [5/4/2022 7:34 AM] |
12.13 |
0.25 (2.10%) |
11.88 |
0.0 (0.00%) |
7.30 - 21.50 |
96,085 |
100,000 |
4,356 |
|
|
03-03-2022 |
PM |
7:00 AM ET (Mar 3) |
EYPT |
EyePoint Pharmaceuticals, Inc. |
337.30 |
-0.59 |
-0.50 |
-1.01 |
EyePoint Pharmaceuticals GAAP EPS of -$0.59 misses by $0.03, revenue of $11.54M beats by $1.75M [3/3/2022 7:02 AM] |
11.04 |
1.23 (12.49%) |
9.81 |
0.0 (0.00%) |
7.30 - 21.50 |
124,658 |
190,000 |
2,317 |
|
|
03-11-2021 |
PM |
7:00 AM ET (Nov 3) |
EYPT |
EyePoint Pharmaceuticals, Inc. |
349.27 |
-0.58 |
-0.47 |
-0.30 |
EyePoint Pharmaceuticals EPS misses by $0.18, misses on revenue [11/3/2021 7:10 AM] |
12.56 |
0.31 (2.50%) |
12.10 |
-0.15 (-1.22%) |
3.70 - 15.06 |
380,528 |
140,000 |
200 |
|
|
04-08-2021 |
PM |
7:00 AM ET (Aug 4) |
EYPT |
EyePoint Pharmaceuticals, Inc. |
236.25 |
-0.35 |
-0.44 |
1.00 |
EyePoint Pharmaceuticals EPS beats by $0.09, beats on revenue [8/4/2021 7:12 AM] |
8.71 |
0.15 (1.75%) |
8.71 |
0.0 (0.00%) |
3.51 - 15.06 |
152,828 |
110,000 |
1,028 |
|
|
05-05-2021 |
PM |
7:00 AM ET (May 5) |
EYPT |
EyePoint Pharmaceuticals, Inc. |
307.25 |
-0.50 |
-0.52 |
-1.10 |
EyePoint Pharmaceuticals EPS beats by $0.01, misses on revenue [5/5/2021 7:09 AM] |
10.85 |
0.44 (4.23%) |
0.0 |
0.0 (0.00%) |
3.51 - 15.06 |
156,074 |
150,000 |
0 |
|
|
04-03-2021 |
PM |
7:00 AM ET (Mar 4) |
EYPT |
EyePoint Pharmaceuticals, Inc. |
310.07 |
-1.01 |
0.45 |
-0.90 |
EyePoint Pharmaceuticals EPS misses by $0.90, misses on revenue [3/4/2021 7:02 AM] |
9.62 |
-1.98 (-17.07%) |
10.81 |
-0.79 (-6.81%) |
3.51 - 15.06 |
753,624 |
300,819 |
14,126 |
|
|
05-11-2020 |
PM |
7:00 AM ET (Nov 5) |
EYPT |
EyePoint Pharmaceuticals, Inc. |
50.62 |
-0.30 |
-0.05 |
-0.14 |
EyePoint Pharmaceuticals EPS beats by $0.01, beats on revenue [11/5/2020 7:11 AM] |
0.3916 |
-0.01 (-2.42%) |
0.3916 |
0.0 (0.00%) |
0.35 - 2.41 |
901,392 |
849,002 |
194 |
|
|
05-08-2020 |
PM |
7:00 AM ET (Aug 5) |
EYPT |
EyePoint Pharmaceuticals, Inc. |
88.57 |
-1.00 |
-0.11 |
-0.11 |
EyePoint Pharmaceuticals EPS beats by $0.01, beats on revenue [8/5/2020 7:05 AM] |
0.6874 |
-0.04 (-5.82%) |
0.71 |
-0.02 (-2.73%) |
0.66 - 2.69 |
570,420 |
387,389 |
35,724 |
|
|
06-05-2020 |
PM |
|
EYPT |
EyePoint Pharmaceuticals, Inc. |
115.15 |
-1.10 |
-0.09 |
-0.16 |
EyePoint Pharmaceuticals EPS misses by $0.01, beats on revenue [5/6/2020 7:04 AM] |
0.8952 |
-0.03 (-3.02%) |
0.90 |
0.0 (0.54%) |
0.70 - 2.69 |
395,267 |
339,858 |
10,311 |
|
|